首页> 外文会议>Society for Biomaterials annual meeting and exposition >Antimicrobial Agent Evaluation Using Planktonic, Biofilm-Forming and Preformed Biofilm Cell States
【24h】

Antimicrobial Agent Evaluation Using Planktonic, Biofilm-Forming and Preformed Biofilm Cell States

机译:使用浮游生物,生物膜形成和预先形成的生物膜细胞状态评估抗菌剂

获取原文

摘要

The characterization of antimicrobial efficacy in three different stages of bacterial growth, including the often overlooked evaluation of preformed biofilms, provides a more comprehensive examination of antimicrobials and further sheds light on potential mechanisms of action. QPS-1 had similar effective concentrations in planktonic cultures and biofilm formation studies, suggesting that its mechanism of action occurs before biofilm formation. However, the small increase (< 10-fold) needed for full antimicrobial activity in preformed biofilms further indicates that the mechanism of action is not as affected in biofilms as compared to antibiotics, which typically require 100 to 1000 fold higher concentrations for anti-biofilm properties. Due to its promising anti-biofilm activities at low concentrations, QPS-1 is a candidate molecule to impart antimicrobial activity to biomaterials.
机译:在细菌生长的三个不同阶段的抗微生物功效的表征,包括经常被忽视的对预制生物膜的评估,提供了对抗微生物剂的更全面的检查,并进一步阐明了潜在的作用机理。 QPS-1在浮游文化和生物膜形成研究中具有相似的有效浓度,表明其作用机理发生在生物膜形成之前。然而,在预制的生物膜中充分发挥抗菌活性所需的少量增加(<10倍)进一步表明,与抗生素相比,作用在生物膜中的作用机理没有受到影响,而抗生素通常需要高100至1000倍的抗生物膜浓度 特性。由于其在低浓度时有希望的抗生物膜活性,QPS-1是向生物材料赋予抗微生物活性的候选分子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号